Propel Bio Partners
Venture capitalLos Angeles · Seed–Series A · 5 people tracked
Investment thesis
Propel Bio Partners LP is an equity investment firm with offices in Los Angeles and Seattle that invests in life science companies developing new technologies and therapies.
Team · 5 people
from the firm's websiteFrequently asked questions
- What stage does Propel Bio Partners invest at?
- Propel Bio Partners invests at the Seed, Series A stages.
- What sectors does Propel Bio Partners focus on?
- Propel Bio Partners focuses on Biotech, Medical Devices.
- Where is Propel Bio Partners located?
- Propel Bio Partners is headquartered in Los Angeles, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.